Integrated Delivery Networks (IDNs) are reshaping U.S. healthcare, influencing care models, costs, and partnerships. Key drivers include pricing pressures, value-based care, and competition, pushing IDNs toward population health programs, advanced analytics, and risk-based contracts. Pharma faces challenges with formulary placement, therapy protocols, and access, as IDNs demand early, collaborative partnerships with shared goals and transparent data. Effective engagement means co-developing value-based agreements, supporting patient adherence, and aligning on outcomes rather than sales pitches. Trends include Medicare Advantage growth, clinical pathway standardization, digital patient activation, and caregiver support. Pharma must adapt with integrated account teams, segmentation strategie

Join for free to read